These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 11299767

  • 1. Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro.
    Milligan SA, Nopajaroonsri C.
    Anticancer Res; 2001; 21(1A):39-44. PubMed ID: 11299767
    [Abstract] [Full Text] [Related]

  • 2. Ubiquitin-proteasome inhibition enhances apoptosis of human pancreatic cancer cells.
    McDade TP, Perugini RA, Vittimberga FJ, Callery MP.
    Surgery; 1999 Aug; 126(2):371-7. PubMed ID: 10455908
    [Abstract] [Full Text] [Related]

  • 3. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
    Sakai T, Kambe F, Mitsuyama H, Ishiguro N, Kurokouchi K, Takigawa M, Iwata H, Seo H.
    J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703
    [Abstract] [Full Text] [Related]

  • 4. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation.
    Watanabe K, Kubota M, Hamahata K, Lin Y, Usami I.
    Biochem Pharmacol; 2000 Sep 15; 60(6):823-30. PubMed ID: 10930537
    [Abstract] [Full Text] [Related]

  • 5. Ubiquitin-proteasome inhibitor enhances tumour necrosis factor-alpha-induced apoptosis in rat gastric epithelial cells.
    Naito Y, Handa O, Takagi T, Ishikawa T, Imamoto E, Nakagawa S, Yamaguchi T, Yoshida N, Matsui H, Yoshikawa T.
    Aliment Pharmacol Ther; 2002 Apr 15; 16 Suppl 2():59-66. PubMed ID: 11966525
    [Abstract] [Full Text] [Related]

  • 6. Effect of NF-kappa B Inhibition on TNF-alpha-induced apoptosis and downstream pathways in cardiomyocytes.
    Bergmann MW, Loser P, Dietz R, von Harsdorf R.
    J Mol Cell Cardiol; 2001 Jun 15; 33(6):1223-32. PubMed ID: 11444925
    [Abstract] [Full Text] [Related]

  • 7. NF-kappaB activation is related to the resistance of lung cancer cells to TNF-alpha-induced apoptosis.
    Kim JY, Lee S, Hwangbo B, Lee CT, Kim YW, Han SK, Shim YS, Yoo CG.
    Biochem Biophys Res Commun; 2000 Jun 24; 273(1):140-6. PubMed ID: 10873576
    [Abstract] [Full Text] [Related]

  • 8. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis.
    Manna SK, Aggarwal BB.
    J Immunol; 1998 Sep 15; 161(6):2863-72. PubMed ID: 9743347
    [Abstract] [Full Text] [Related]

  • 9. Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells.
    Németh ZH, Wong HR, Odoms K, Deitch EA, Szabó C, Vizi ES, Haskó G.
    Mol Pharmacol; 2004 Feb 15; 65(2):342-9. PubMed ID: 14742676
    [Abstract] [Full Text] [Related]

  • 10. Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells.
    McDade TP, Perugini RA, Vittimberga FJ, Carrigan RC, Callery MP.
    J Surg Res; 1999 May 01; 83(1):56-61. PubMed ID: 10210643
    [Abstract] [Full Text] [Related]

  • 11. Activation of NF-kappa B by phosphatase inhibitors involves the phosphorylation of I kappa B alpha at phosphatase 2A-sensitive sites.
    Sun SC, Maggirwar SB, Harhaj E.
    J Biol Chem; 1995 Aug 04; 270(31):18347-51. PubMed ID: 7629157
    [Abstract] [Full Text] [Related]

  • 12. Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.
    Sunwoo JB, Chen Z, Dong G, Yeh N, Crowl Bancroft C, Sausville E, Adams J, Elliott P, Van Waes C.
    Clin Cancer Res; 2001 May 04; 7(5):1419-28. PubMed ID: 11350913
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132.
    Fiedler MA, Wernke-Dollries K, Stark JM.
    Am J Respir Cell Mol Biol; 1998 Aug 04; 19(2):259-68. PubMed ID: 9698598
    [Abstract] [Full Text] [Related]

  • 14. Proteasome regulation of Fas ligand cytotoxicity.
    Matsui K, Omura S, Cui H, Schauer SL, Sonenshein GE, Ju ST.
    Eur J Immunol; 1997 Sep 04; 27(9):2269-78. PubMed ID: 9341769
    [Abstract] [Full Text] [Related]

  • 15. The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis.
    Delic J, Masdehors P, Omura S, Cosset JM, Dumont J, Binet JL, Magdelénat H.
    Br J Cancer; 1998 Apr 04; 77(7):1103-7. PubMed ID: 9569046
    [Abstract] [Full Text] [Related]

  • 16. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
    Nencioni A, Wille L, Dal Bello G, Boy D, Cirmena G, Wesselborg S, Belka C, Brossart P, Patrone F, Ballestrero A.
    Clin Cancer Res; 2005 Jun 01; 11(11):4259-65. PubMed ID: 15930365
    [Abstract] [Full Text] [Related]

  • 17. Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer.
    Denlinger CE, Keller MD, Mayo MW, Broad RM, Jones DR.
    J Thorac Cardiovasc Surg; 2004 Apr 01; 127(4):1078-86. PubMed ID: 15052205
    [Abstract] [Full Text] [Related]

  • 18. Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation.
    Prösch S, Priemer C, Höflich C, Liebenthaf C, Babel N, Krüger DH, Volk HD.
    Antivir Ther; 2003 Dec 01; 8(6):555-67. PubMed ID: 14760889
    [Abstract] [Full Text] [Related]

  • 19. The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells.
    Giuliano M, Lauricella M, Calvaruso G, Carabillò M, Emanuele S, Vento R, Tesoriere G.
    Cancer Res; 1999 Nov 01; 59(21):5586-95. PubMed ID: 10554039
    [Abstract] [Full Text] [Related]

  • 20. IFNalpha sensitizes ME-180 human cervical cancer cells to TNFalpha-induced apoptosis by inhibiting cytoprotective NF-kappaB activation.
    Suk K, Kim YH, Chang I, Kim JY, Choi YH, Lee KY, Lee MS.
    FEBS Lett; 2001 Apr 20; 495(1-2):66-70. PubMed ID: 11322949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.